Manmeet Singh Soni
Vermögen: 55 Mio $ am 31.05.2026
Vermögen: 55 Mio $ am 31.05.2026
Herr Manmeet Singh Soni, CPA, ist Executive VP, Chief Operating & Financial Officer bei Reata Pharmaceuticals, Inc. und ein unabhängiger Non-Executive Director bei Arena Pharmaceuticals, Inc. sowie ein unabhängiger Director bei Pulse Biosciences, Inc. und ein unabhängiger Director bei Summit Therapeutics, Inc. Er ist Mitglied des Board of Directors bei Summit Therapeutics Ltd., Arena Pharmaceuticals, Inc. und Pulse Biosciences, Inc. Herr Soni war zuvor als Senior VP, Chief Financial & Accounting Officer bei Alnylam Pharmaceuticals, Inc. tätig, als Chief Financial Officer & Treasurer bei ARIAD Pharmaceuticals, Inc. und als Chief Financial Officer & Treasurer bei Pharmacyclics, Inc. sowie als Controller & Senior Director-Finance bei ZELTIQ Aesthetics, Inc. und als Senior Manager-Life Science bei PricewaterhouseCoopers LLP. Außerdem war er Vorstandsmitglied bei Genoscience Pharma. Seinen Bachelor-Abschluss erhielt er am Hansraj College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.06.2026 | 3.123.603 ( 0,4 % ) | 55 Mio $ | 31.05.2026 | |
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PULSE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 02.11.2017 |
| SUMMIT THERAPEUTICS INC. | Finanzdirektor/CFO | 02.04.2024 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of novel medicines | Direktor/Vorstandsmitglied | 24.12.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 26.09.2023 |
| ARENA PHARMACEUTICALS | Direktor/Vorstandsmitglied | 11.06.2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 12.08.2019 |
Genoscience Pharma
Genoscience Pharma BiotechnologyHealth Technology Operates as a biotech company that develops unique small molecules in oncology | Direktor/Vorstandsmitglied | 01.11.2017 |
| ARIAD PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.02.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of novel medicines | Health Technology |
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
ZELTIQ Aesthetics, Inc.
ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that develops non-invasive procedures for the reduction of unwanted fat tissue | Health Technology |
Pulse Biosciences, Inc.
Pulse Biosciences, Inc. Medical SpecialtiesHealth Technology Operates as a bioelectric medicine company which develops medical devices | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Genoscience Pharma
Genoscience Pharma BiotechnologyHealth Technology Operates as a biotech company that develops unique small molecules in oncology | Health Technology |
Hansraj College
Hansraj College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Summit Therapeutics, Inc.
Summit Therapeutics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition